Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05248711 · ClinicalTrials.gov registry record · NA
Project Movement/Daily Move Feasibility
A NA study, sponsored by Calm.com.
- Terminated
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT05248711: Clinical Trial NA study, sponsored by Calm.com.
NCT05248711 is a NA study that was terminated before completion, run by Calm.com. The registered enrollment target is 137 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05248711, a NA study, was terminated before completion, sponsored by Calm.com.
- TERMINATED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
The purpose of this study is to test the feasibility (acceptability and demand) of the Daily Move in a diverse sample of US adults. Acceptability benchmarks: 214 participants recruited within three months (60% will identify as a racial/ethnic minority; 30% African American, 30% Hispanic); At least 70% of participants rate the intervention as satisfactory. Demand benchmarks: At least 70% of participants complete 75% of prescribed Daily Move sessions per week across the 8-weeks; Dropouts not to exceed \>30% of participants. Aim 2 - explore the pre-post trends in change of: Stress - Perceived Stress Scale (PSS), Anxiety and Depression - Hospital Anxiety and Depression Scale (HADS), Mindfulness- Mindful Attention Awareness Scale (MAAS), and Mood- Profile of Mood States (POMS).
Interventions
- BEHAVIORAL Calm Daily Move
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2022-01-06 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05248711
The ClinicalTrials.gov registry entry for NCT05248711 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Calm.com, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calm Daily Move is the first listed.
NCT05248711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05248711 about?
NCT05248711 is a clinical study titled "Project Movement/Daily Move Feasibility". The purpose of this study is to test the feasibility (acceptability and demand) of the Daily Move in a diverse sample of US adults. Acceptability benchmarks: 214 participants recruited within three months (60% will identify as a racial/ethnic minority; 30% African American, 30% Hispanic); At least 7...
What is the current status of trial NCT05248711?
This trial is currently terminated. It is a NA study. The enrollment target is 137 participants. The study started on 2022-01-06. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT05248711?
The interventions under investigation include: Calm Daily Move (BEHAVIORAL).
Who is sponsoring clinical trial NCT05248711?
This trial is sponsored by Calm.com, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.